Orthofix Medical Inc.

Health Care
Medical/Dental Instruments
www.orthofix.com

Earnings Score
Moat Score
Safety Score

Market Cap $459.89M
PE -4
Debt $157.02M
Cash $83.24M
EV $533.67M
FCF -$9.09M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$126.00M
EBIT	-$84.62M
ROE	-25%
ROA	-9%
FCF	-$9.09M
Equity	$503.12M
Growth Stability	-370%
PE	-3.65
PB	0.91
P/FCF	-50.62
P/S	0.58
Price/Cash	0.18
Debt/Equity	0.31
Debt/FCF	-17.28
Net Margins	-16%
Gross Margins	68%
Op. Margins	-11%
Earnings CAGR	0%
Sales Growth YoY	8%
Sales Growth QoQ	10%
Sales CAGR	7%
FCF CAGR	-1%
Equity CAGR	8%
Earnings Stability	0
Earnings Growth YoY	31%

Earnings Growth QoQ	6%
Sales CAGR 5Y	17%
FCF CAGR 5Y	-3%
Equity CAGR 5Y	14%
Earnings CAGR 3Y	28%
Sales CAGR 3Y	28%
Equity CAGR 3Y	22%
Market Cap	$459.89M
Revenue	$799.49M
Assets	$893.29M
Total Debt	$157.02M
Cash	$83.24M
Shares Outstanding	38.13M
EV	533.67M
Earnings Score	6%
Moat Score	4%
Safety Score	39%
Final Score	16%
Working Capital	264.66M
Current Ratio	2.57
Gross Profit	$545.89M
Shares Growth 3y	34%
Equity Growth QoQ	-4%
Equity Growth YoY	-16%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

SEC Filings

Direct access to Orthofix Medical Inc. (OFIX) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Orthofix Medical Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Orthofix Medical Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 0%

Stability 0%

loading chart...

Orthofix Medical Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Orthofix Medical Inc..

Years

Calculation mode

= -$83M

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	-$9.1M	-$9M	-$8.9M	-$8.7M	-$8.6M	-$8.5M	-$8.4M	-$8.3M	-$8.2M	-$8.1M	-$8M	-$80M
DCF		-$8.2M	-$7.3M	-$6.6M	-$5.9M	-$5.3M	-$4.7M	-$4.3M	-$3.8M	-$3.4M	-$3.1M	-$31M
Value	-$83M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	12/2024	TTM
Net Margins	-1%	1%	1%	3%	-6%	1%	-8%	-4%	-20%	-16%	-16%
ROA	-	6%	10%	6%	-4%	-0%	-2%	-3%	-15%	-9%	-9%
ROE	-	1%	2%	4%	-9%	1%	-11%	-6%	-25%	-25%	-25%

Bad Net Margins (-15.76%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	12/2024	TTM
Debt over FCF	-	-	-	-	-	-	-	-	-0.89	-17.28	-17.28
Debt over Equity	-	-	-	-	-	-	-	-	0.16	0.31	0.31
Growth Stability	-	-	-	100%	-370%	-	-	-	-	-	-370%

Good Debt/FCF ratio (-17.28)

Net Margins are high enough to offer a good protection on the profits in case of higher costs or higher interests. Furthermore higher margins reduce earnings’ volatility.

Good Debt/Equity ratio (0.31)

The company is not overleveraged and has a good balance between equity and debt.

Bad Graham’s Stability (-370%)

The company has a bad stability in its earnings, which is a sign of a bad competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	12/2024	CAGR 5Y
Revenue YoY growth	-	3%	6%	4%	2%	-12%	14%	-1%	62%	7%	17%
Earnings YoY growth	-	-209%	104%	122%	-306%	-109%	-2K%	-49%	667%	-17%	-
Equity YoY growth	-	-9%	13%	13%	-2%	9%	-6%	-0%	78%	-16%	14%
FCF YoY growth	-	76%	37%	-6%	-64%	351%	-99%	-5K%	211%	-92%	-3%